Last reviewed · How we verify
NCT07512479
Effectiveness of Hatha Yoga and From Feeling to Seeing the Body (FSB) in Female Adolescents and Young Adults With Eating Disorders.
NA trial testing Hatha Yoga Group (Y) in Body Image in 54 participants. Completed in 27 January 2026.
1 October 2025
Quick facts
| Lead sponsor | Azienda Ulss 2 Marca Trevigiana |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 10 March 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 27 January 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Hatha Yoga Group (Y)
- From Feeling to Seeing the Body Group (FSB)
- Control Group (C)
Conditions studied
- Body Image — all drugs for Body Image →
- Eating Disorders — all drugs for Eating Disorders →
- Anorexia Nervosa — all drugs for Anorexia Nervosa →
- Bulimia Nervosa — all drugs for Bulimia Nervosa →
Sponsor
Azienda Ulss 2 Marca Trevigiana
Who can join
Adults 16 to 25, female only, with Body Image or Eating Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate the effectiveness of two types of intervention (Hatha Yoga and FSB From Feeling to Seeing the Body - Embodied Experience Intervention for body image) on eating behaviour and body dissatisfaction in females aged 16-25 with eating disorders. The main questions the study aims to answer are: * Do Hatha Yoga and FSB Intervention have an impact on eating behavior and reductions in body dissatisfaction? * How do Hatha Yoga and FSB Intervention influence underlying mechanisms such as embodiment, interoceptive awareness, body and functionality appreciation, mindfulness and self-compassion? Researchers will compare the outcomes with a control group that will receive only standard treatment to determine whether the specific Hatha Yoga and FSB interventions have an impact on body dissatisfaction and eating behaviors. Participants will be divided into three groups: * Control Group (C): patients will continue with treatment as usual (TAU) which consists of periodic psychiatric, psychotherapeutic, nutritional and dietetic visits. * Hatha Yoga Group (Y): patients will continue TAU and will additionally attend one weekly Hatha Yoga session. * From Feeling to Seeing the Body Group (FSB): patients will continue TAU and will additionally attend one weekly FSB session.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07512479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Body Image
Currently open trials in the same condition.
- NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
- NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting
- NCT07327125 — Effect of Skin Closure Techniques on Body Image in Women Undergoing Gynecologic Surgery · NA · recruiting
- NCT07113678 — The Impact of a Podcast-based Body Image Intervention Among Millennial Women · NA · recruiting
- NCT07023822 — WISH, Feasibility of a Factorial Design · NA · active not recruiting
Other Azienda Ulss 2 Marca Trevigiana trials
Trials by the same sponsor.
- NCT06409039 — POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognost · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07512479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ulss 2 Marca Trevigiana
- Last refreshed: 6 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07512479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing